Combined target-based and ligand-based drug design approach as a tool to define a novel 3D-pharmacophore model of human A3 adenosine receptor antagonists: pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as a key study (Q45212811)
Jump to navigation
Jump to search
scientific article published in January 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combined target-based and ligand-based drug design approach as a tool to define a novel 3D-pharmacophore model of human A3 adenosine receptor antagonists: pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as a key study |
scientific article published in January 2005 |
Statements
1 reference
Combined target-based and ligand-based drug design approach as a tool to define a novel 3D-pharmacophore model of human A3 adenosine receptor antagonists: pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as a key study (English)
1 reference
1 reference
Paolo Braiuca
1 reference
Francesca Deflorian
1 reference
Cristina Ferrari
1 reference
Giorgia Pastorin
1 reference
Barbara Cacciari
1 reference
Pier Giovanni Baraldi
1 reference
Katia Varani
1 reference
Pier Andrea Borea
1 reference
Giampiero Spalluto
1 reference
1 January 2005
1 reference
1 reference
Identifiers
1 reference